For musculoskeletal or systemic targets, injections are the better-supported route based on existing animal data
People interested in improving liver health and overall metabolic function
You may need different amounts of your medicine, or you may need to take different medicines
Treatment with once-weekly cagrilintide (0.16, 0.30, 0.60, 1.2, 2.4, and 4.5 mg) in combination with semaglutide 2.4 mg for 20 weeks was not associated with an increase in adverse events compared with placebo in combination with semaglutide 2.4 mg, with no unexpected safety or tolerability findings
Without supplementation or fortified foods, deficiency is almost inevitable over time
Quality documentation, traceability, storage guidance and transparent supplier standards are also important